Recent

% | $
Quotes you view appear here for quick access.

Celgene Corporation Message Board

  • Rob_Cos Rob_Cos Dec 31, 1997 2:27 PM Flag

    Celgene will soar in 98

    I have been following a company in my home state of New
    Jersey called Celgene (CELG).Have you heard of it - could
    you research it and give me your opinion on it?
    I really think this stock will soar in 1998 for many
    reasons.They could get approval for thalidomide{that's right
    this nightmare drug of the 60's is turning out to be a
    godsend for many ailments) in early 1998; potential sales
    have been estimated at $60-$100 million, and could be even
    higher depending on off-label use, which will certainly be
    significant but cannot easily be predicted; remember,
    thalidomide inhibits TNF alpha, and analysts
    have projected that sales of Immunex's TNF alpha inhibitor
    could reach $1 billion in treating rheumatoid arthritis. In
    the past few months, CELG announced great results of its
    chirally pure ritalin, which has sales of $400 million in
    unpure form, and chirally pure mexilitene, which could be
    the first effective treatment for neuropathic pain, which is
    felt by a million people worldwide. The company is in late
    negotiations with BASF to license CELG's chiral agrochemical
    technology, which would flow right to the bottom line for
    many years. Add
    in the SelCIDs and analogs and I look at this company as six
    awesome opportunities rolled into one. Usually when you are
    looking at a microcap biotech you're pinning all your hopes
    on one drug, and if it fails, the stock disappears. This
    company has the only proven chiral agrochemical technology
    in the world, drugs for ADD and neuropathic pain, and
    thalidomide and its analogs which could treat
    AIDs conditions, rheumatoid arthritis, colitis, lupus, etc,
    etc.(illegally imported thalidomide is being used by a
    siginificant number of Aids-wasting victims, obviously the
    FDA is concerned about this). And it now has certain
    funding from the sale of its intermediate business
    for $15 million and has raised $40 through a recent
    offering. Despite two very recent BUY recommendations with a
    target price of $17, I can't help but think that this stock
    is awfully overlooked and undervalued at around 8 3/8. I
    have followed it closely and would encourage eveyone to get
    the full investors package by calling 908-271-4102. It is
    definitely headed much higher in 1998. This is not hype, I
    have followed it closely and 98 will be its year. BTW, Board
    memobers include Arthur Hull Hayes, former FDA Commissioner,
    the former CEO of IBM and Lee Schroeder, the former Exec VP
    from Sandoz. Celgene has an excellent relationship with the
    FDA. 98 should be filled with excitement.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I have been following a company in my home state of New Jersey called Celgene (CELG).Have you heard of it - could you research it and give me your opinion on it? I really think this stock will soar in 1998 for many reasons.They could get approval for thalidomide{that's right this nightmare drug of the 60's is turning out to be a godsend for many ailments) in early 1998; potential sales have been estimated at $60-$100 million, and could be even higher depending on off-label use, which will certainly be significant but cannot easily be predicted; remember, thalidomide inhibits TNF alpha, and analysts have projected that sales of Immunex's TNF alpha inhibitor could reach $1 billion in treating rheumatoid arthritis. In the past few months, CELG announced great results of its chirally pure ritalin, which has sales of $400 million in unpure form, and chirally pure mexilitene, which could be the first effective treatment for neuropathic pain, which is felt by a million people worldwide. The company is in late negotiations with BASF to license CELG's chiral agrochemical technology, which would flow right to the bottom line for many years. Add in the SelCIDs and analogs and I look at this company as six awesome opportunities rolled into one. Usually when you are looking at a microcap biotech you're pinning all your hopes on one drug, and if it fails, the stock disappears. This company has the only proven chiral agrochemical technology in the world, drugs for ADD and neuropathic pain, and thalidomide and its analogs which could treat AIDs conditions, rheumatoid arthritis, colitis, lupus, etc, etc.(illegally imported thalidomide is being used by a siginificant number of Aids-wasting victims, obviously the FDA is concerned about this). And it now has certain funding from the sale of its intermediate business for $15 million and has raised $40 through a recent offering. Despite two very recent BUY recommendations with a target price of $17, I can't help but think that this stock is awfully overlooked and undervalued at around 8 3/8. I have followed it closely and would encourage eveyone to get the full investors package by calling 908-271-4102. It is definitely headed much higher in 1998. This is not hype, I have followed it closely and 98 will be its year. BTW, Board memobers include Arthur Hull Hayes, former FDA Commissioner, the former CEO of IBM and Lee Schroeder, the former Exec VP from Sandoz. Celgene has an excellent relationship with the FDA. 98 should be filled with excitement.

    • For the newbies who don't know who to trust in this epic battle of long verse shorts, I re-post Message #8 on this board from Robcos, when CELG traded at an adjusted $1.30.


      Celgene will soar in 98
      by: Rob_Cos 12/31/97 02:27 pm
      Msg: 12 of 84091

      I have been following a company in my home state of New Jersey called Celgene (CELG).Have you heard of it - could you research it and give me your opinion on it? I really think this stock will soar in 1998 for many reasons.They could get approval for thalidomide{that's right this nightmare drug of the 60's is turning out to be a godsend for many ailments) in early 1998; potential sales have been estimated at $60-$100 million, and could be even higher depending on off-label use, which will certainly be significant but cannot easily be predicted; remember, thalidomide inhibits TNF alpha, and analysts have projected that sales of Immunex's TNF alpha inhibitor could reach $1 billion in treating rheumatoid arthritis. In the past few months, CELG announced great results of its chirally pure ritalin, which has sales of $400 million in unpure form, and chirally pure mexilitene, which could be the first effective treatment for neuropathic pain, which is felt by a million people worldwide. The company is in late negotiations with BASF to license CELG's chiral agrochemical technology, which would flow right to the bottom line for many years. Add in the SelCIDs and analogs and I look at this company as six awesome opportunities rolled into one. Usually when you are looking at a microcap biotech you're pinning all your hopes on one drug, and if it fails, the stock disappears. This company has the only proven chiral agrochemical technology in the world, drugs for ADD and neuropathic pain, and thalidomide and its analogs which could treat AIDs conditions, rheumatoid arthritis, colitis, lupus, etc, etc.(illegally imported thalidomide is being used by a siginificant number of Aids-wasting victims, obviously the FDA is concerned about this). And it now has certain funding from the sale of its intermediate business for $15 million and has raised $40 through a recent offering. Despite two very recent BUY recommendations with a target price of $17, I can't help but think that this stock is awfully overlooked and undervalued at around 8 3/8. I have followed it closely and would encourage eveyone to get the full investors package by calling 908-271-4102. It is definitely headed much higher in 1998. This is not hype, I have followed it closely and 98 will be its year. BTW, Board memobers include Arthur Hull Hayes, former FDA Commissioner, the former CEO of IBM and Lee Schroeder, the former Exec VP from Sandoz. Celgene has an excellent relationship with the FDA. 98 should be filled with excitement.

    • Boy did you waste a lot of money backing this dog.

      I am of course joking. I am actually amazed at your insight over a 7 1/2 year period. And the soaring still isn't done.

    • Wow, I was just poking around trying to see who's still on this board since the start and found Rob Cos' first post. You were right on track with your initial analysis. Would anyone ever have thought that this stock would be at $55 (after 3:1 split) today. Just think would anyone have imagined back then making 60x their money in 7 years? Food for thought......

    • The mention of the occurrence of diarrhea is not a negative at all. CAMPTOSAR is the primary therapy for patients suffering colon cancer and one of the main reasons it fails is that it causes potentially deadly diarrhea. One of the main reasons they conducted a trial of CAMPTOSAR together with THALOMID is that the latter is known to reduce severe diarrhea. The release stated that 11% of patients suffered this side effect, while 22% of patients treated with CAMPTOSAR alone did - in other words, adding THALOMID to the mixed reduces by 50% the number of patients suffering from it. This is an excellent result !

    • Not helping stock price at this moment. Something must have scared investors. The only negative was occurence of diarrhea in some patients.
      This market can turn any positive into a negative.

    • I picked up 3000 more under 19 and will do so again if it drops back.
      Thal sales are accelerating again in May and the awareness this weekend and next week will help generate a surge to new levels.
      The quantity and quality of trials are indeed impressive and once SelCids proceed a little further the potential of this company will start to excite even the most skeptical biotech investor.
      I said it last week and I say it again - I haven't felt this good about the apprecition potential since the early yahoo days at 8 3/8 pre-split before the run to $210 split adjusted. That was post 12 of 28,669!
      I feel that good once again!

      http://messages.yahoo.com/bbs?.mm=FN&board=7078974&tid=celg&sid=7078974&action=m
      &mid=12

    • Even if posts are crap and are only glanced at
      and not absorbed by the reader, Yahoo posts ads on
      many pages with crap posts and makes money.

      Get
      rid of the crap posts -- reduce the number of
      scaffolds on which to hang adds by 1/2, and Yahoo's income
      drops by 1/2.

      Maybe they want the crap. Our
      bottom line may be quality posts with minimum clutter,
      but their bottom line is advertising
      revenue.

      enzyman

    • I didn't think I'd ever see such a
      beautiful
      sight!! That is watching a moron like Thaldonumskull
      trying to
      profess that it has just won
      victory
      over the Celgene Board when at the
      same time the
      powers to be (Yahoo)
      are erasing its empty worded
      mssgs.
      Score 1 for Yahoo.

      Glsfutrs

    • page on the central yahoo cite to send in a
      request. I just did informing them of how many people are
      jumping ship. They get paid by the advertisers by how
      many hits a page gets so they dont' want to loose
      anyone. Or on the other hand they don't care since people
      slog through the crap and make their hits for them. I
      just figured out the ignore button on RB and compared
      to yahoo i could save hours per day I think. The y
      even have spell check on RB which I need.

      dave

    • View More Messages
 
CELG
98.82+0.01(+0.01%)1:03 PMEDT